Analyze Diet

Topic:Intramuscular Administration

Intramuscular administration in horses involves the injection of medications directly into the muscle tissue. This method is commonly used for delivering vaccines, antibiotics, and other therapeutic agents. The technique requires knowledge of equine anatomy to ensure the injection is placed in the correct location, such as the neck or hindquarters, to minimize discomfort and avoid complications. Proper intramuscular administration can facilitate the absorption of medications into the bloodstream, allowing for effective therapeutic interventions. This page compiles peer-reviewed research studies and scholarly articles that explore the techniques, benefits, and potential complications associated with intramuscular administration in equine practice.
Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses.
American journal of veterinary research    May 25, 2012   Volume 73, Issue 6 799-808 doi: 10.2460/ajvr.73.6.799
Figueiredo JP, Muir WW, Sams R.To compare the cardiorespiratory, gastrointestinal, analgesic, and behavioral effects between IV and IM administration of morphine in conscious horses with no signs of pain. Methods: 6 healthy adult horses. Methods: Horses received saline (0.9% NaCl) solution (IM or IV) or morphine sulfate (0.05 and 0.1 mg/kg, IM or IV) in a randomized, masked crossover study design. The following variables were measured before and for 360 minutes after drug administration: heart and respiratory rates; systolic, diastolic, and mean arterial blood pressures; rectal temperature; arterial pH and blood gas variabl...
Evaluation of intramuscularly administered sodium pentosan polysulfate for treatment of experimentally induced osteoarthritis in horses.
American journal of veterinary research    April 27, 2012   Volume 73, Issue 5 628-633 doi: 10.2460/ajvr.73.5.628
McIlwraith CW, Frisbie DD, Kawcak CE.To assess clinical, radiographic, histologic, and biochemical effects of sodium pentosan polysulfate (NaPPS) administered IM for treatment of experimentally induced osteoarthritis in horses. Methods: 18 horses. Methods: Osteoarthritis was induced arthroscopically in 1 middle carpal joint of all horses. Nine horses received NaPPS (3 mg/kg, IM) on study days 15, 22, 29, and 36. Nine control horses received the same volume of saline (0.9% NaCl) solution IM on study days 15, 22, 29, and 36. Clinical, radiographic, gross, histologic, histochemical, and biochemical findings as well as findings of sy...
Pharmacokinetics of stanozolol in Thoroughbred horses following intramuscular administration.
Journal of veterinary pharmacology and therapeutics    April 11, 2012   Volume 36, Issue 2 201-204 doi: 10.1111/j.1365-2885.2012.01393.x
Moeller BC, Sams RA, Guingab-Cagmat JD, Szabo NJ, Colahan P, Stanley SD.No abstract available
Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses.
American journal of veterinary research    September 2, 2011   Volume 72, Issue 9 1234-1242 doi: 10.2460/ajvr.72.9.1234
Soma LR, Uboh CE, You Y, Guan F, Boston RC.To compare pharmacokinetics of triamcinolone acetonide (TA) following i.v., intra-articular (i.a.), and i.m. administration and determine its effect on plasma concentrations of hydrocortisone and cortisone. Methods: 6 Thoroughbreds. Methods: TA (0.04 mg/kg) was administered i.v., i.m., or i.a., and plasma TA, hydrocortisone, and cortisone concentrations were determined. Results: I.v. administration of TA was fitted to a 2-compartment model. Median distribution half-life was 0.50 hours (range, 0.24 to 0.67 hours); elimination half-life was 6.1 hours (range, 5.0 to 6.4 hours). Transfer half-life...
Plasma and pulmonary disposition of ceftiofur and its metabolites after intramuscular administration of ceftiofur crystalline free acid in weanling foals.
Journal of veterinary pharmacology and therapeutics    May 24, 2011   Volume 35, Issue 3 259-264 doi: 10.1111/j.1365-2885.2011.01311.x
Credille BC, Giguère S, Berghaus LJ, Burton AJ, Sturgill TL, Grover GS, Donecker JM, Brown SA.The objectives of this study were to determine the plasma and pulmonary disposition of ceftiofur crystalline free acid (CCFA) in weanling foals and to compare the plasma pharmacokinetic profile of weanling foals to that of adult horses. A single dose of CCFA was administered intramuscularly to six weanling foals and six adult horses at a dose of 6.6 mg/kg of body weight. Concentrations of desfuroylceftiofur acetamide (DCA) were determined in the plasma of all animals, and in pulmonary epithelial lining fluid (PELF) and bronchoalveolar lavage (BAL) cells of foals. After intramuscular (IM) admin...
Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals.
Journal of veterinary pharmacology and therapeutics    March 28, 2011   Volume 35, Issue 1 59-66 doi: 10.1111/j.1365-2885.2011.01292.x
Berghaus LJ, Giguère S, Sturgill TL, Bade D, Malinski TJ, Huang R.The objectives of this study were to determine the plasma and pulmonary disposition of gamithromycin in foals and to investigate the in vitro activity of the drug against Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) and Rhodococcus equi. A single dose of gamithromycin (6 mg/kg of body weight) was administered intramuscularly. Concentrations of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and blood neutrophils were determined using HPLC with tandem mass spectrometry detection. The minimum inhibitory concentration of gamithr...
Effects of two methods of administration on the pharmacokinetics of ceftiofur crystalline free acid in horses.
Journal of veterinary pharmacology and therapeutics    March 15, 2011   Volume 34, Issue 2 193-196 doi: 10.1111/j.1365-2885.2010.01224.x
Giguère S, Sturgill TL, Berghaus LJ, Grover GS, Brown SA.No abstract available
Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Journal of veterinary pharmacology and therapeutics    March 11, 2011   Volume 35, Issue 1 52-58 doi: 10.1111/j.1365-2885.2011.01284.x
Davis JL, Messenger KM, LaFevers DH, Barlow BM, Posner LP.The purpose of this study was to determine the pharmacokinetics of buprenorphine following intravenous (i.v.) and intramuscular (i.m.) administration in horses. Six horses received i.v. or i.m. buprenorphine (0.005 mg/kg) in a randomized, crossover design. Plasma samples were collected at predetermined times and horses were monitored for adverse reactions. Buprenorphine concentrations were measured using ultra-performance liquid chromatography with electrospray ionization mass spectrometry. Following i.v. administration, clearance was 7.97±5.16 mL/kg/min, and half-life (T(1/2)) was 3.58 h (ha...
An interlaboratory study of the pharmacokinetics of testosterone following intramuscular administration to Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    March 2, 2011   Volume 34, Issue 6 588-593 doi: 10.1111/j.1365-2885.2011.01277.x
Moeller BC, Sams RA, Guinjab-Cagmat J, Szabo NJ, Colahan P, Stanley SD.Testosterone is an anabolic androgenic steroid (AAS) that is endogenously produced by both male and female horses that also has the potential for abuse when administered exogenously to race horses. To recommend appropriate withdrawal guidelines so that veterinarians can discontinue therapeutic use prior to competition, the pharmacokinetics and elimination of testosterone were investigated. An aqueous testosterone suspension was administered intramuscularly in the neck of Thoroughbred horses (n = 20). The disposition of testosterone from this formulation was characterized by an initial, rapid a...
Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equine.
Journal of veterinary pharmacology and therapeutics    February 16, 2011   Volume 34, Issue 5 476-481 doi: 10.1111/j.1365-2885.2011.01266.x
Collard WT, Cox SR, Lesman SP, Grover GS, Boucher JF, Hallberg JW, Robinson JA, Brown SA.Absolute bioavailability and dose proportionality studies were performed with ceftiofur in horses. In the absolute bioavailability study, thirty animals received either an intravenous dose of ceftiofur sodium at 1.0 mg/kg or an intramuscular (i.m.) dose of ceftiofur crystalline-free acid (CCFA) at 6.6 mg/kg. In the dose proportionality study, 48 animals received daily i.m. ceftiofur sodium injections at 1.0 mg/kg for ten doses or two doses of CCFA separated by 96 h, with CCFA doses of 3.3, 6.6, or 13.2 mg/kg. Noncompartmental and mixed-effect modeling procedures were used to assess pharmacokin...
Bioavailability of detomidine administered sublingually to horses as an oromucosal gel.
Journal of veterinary pharmacology and therapeutics    January 12, 2011   Volume 34, Issue 1 76-81 doi: 10.1111/j.1365-2885.2010.01193.x
Kaukinen H, Aspegrén J, Hyyppä S, Tamm L, Salonen JS.The objective of the study was to determine the absorption, bioavailability and sedative effect of detomidine administered to horses as an oromucosal gel compared to intravenous and intramuscular administration of detomidine injectable solution. The study was open and randomized, with three sequences crossover design. Nine healthy horses were given 40 μg/kg detomidine intravenously, intramuscularly or administered under the tongue with a 7-day wash-out period between treatments. Blood samples were collected before and after drug administration for the measurement of detomidine concentration...
Effects of inactivated parapoxvirus ovis on the cumulative incidence of pneumonia and cytokine secretion in foals on a farm with endemic infections caused by Rhodococcus equi.
Veterinary immunology and immunopathology    January 8, 2011   Volume 140, Issue 3-4 237-243 doi: 10.1016/j.vetimm.2010.12.012
Sturgill TL, Giguère S, Franklin RP, Cohen ND, Hagen J, Kalyuzhny AE.The objectives of the present study were to determine if administration of inactivated parapoxvirus ovis (IPPVO) can decrease the cumulative incidence of pneumonia and increase the number of IFN-γ- and IL-4-secreting cells among foals. Fifty-nine foals were randomly assigned to 2 treatment groups (IPPVO or placebo) prior to birth. At 24-48 h of age, foals received 2 ml of either IPPVO or a placebo by intramuscular injection. Injections were repeated 24h and 8 days later. The number of IFN-γ- and IL-4-secreting cells was measured using a validated ELISPOT assay on blood mononuclear cells coll...
A preliminary study on the changes in some potential markers of muscle-cell degradation in sub-maximally exercised horses supplemented with a protein and amino acid mixture.
Journal of animal physiology and animal nutrition    December 1, 2010   Volume 95, Issue 5 664-675 doi: 10.1111/j.1439-0396.2010.01097.x
van den Hoven R, Bauer A, Hackl S, Zickl M, Spona J, Zentek J.In this preliminary study, time-dependent changes in plasma CK and AST activity, tyrosine (Tyr), 3-methyl-histidine (3mHis), glucose and lactate concentrations were analysed in nine horses under two different conditions. Furthermore, intramuscular concentrations of Tyr, 3mHis and activities of cathepsin B, acid phosphatase (ACP), glucose-6-phosphate dehydrogenase (G6PDH) and mRNA expression of ubiquitin were determined at the same time. After studying the effects of exercise alone, the effects of exercise and feeding of an experimental protein/amino acid (AA) supplement were analysed. Horses w...
Efficacy of intramuscular polysulfated glycosaminoglycan in a controlled study of equine carpitis.
Journal of veterinary pharmacology and therapeutics    July 22, 2010   Volume 33, Issue 4 357-362 doi: 10.1111/j.1365-2885.2009.01154.x
Verde C, Ferrante M, Simpson MI, Babusci M, Broglia G, Landoni MF.Twelve healthy horses were subject to the monoioidoacetate (MIA) carpitis model, which was allowed to develop for 7 days. The horses were then randomly divided into two groups. Group A (control) received an intramuscular injection of normal saline every 4 days for a total of seven injections while group B received 500 mg of a PSGAG (SYNTEX CSY36) intramuscularly every 4 days for seven treatments. Efficacy of the PSGAG was evaluated by three clinical outcomes: lameness score, carpal circumference and maximum carpal flexion. Clinical outcomes were measured on days -8 (previous to carpitis induct...
Ceftiofur derivates in serum and endometrial tissue after intramuscular administration in healthy mares.
Theriogenology    May 21, 2010   Volume 74, Issue 3 466-472 doi: 10.1016/j.theriogenology.2010.02.030
Witte TS, Bergwerff AA, Scherpenisse P, Drillich M, Heuwieser W.Endometritis is one of the major problems in the horse breeding industry. The use of antibiotics for treatment of endometritis in the mare is recommended as best practice. The intrauterine application of antibiotics, however, has been under discussion over the last years because of concerns about its efficacy. The systemic use of antibiotics has been considered more effective because of its better distribution within the uterus. The objective of the present study was to determine the concentration of ceftiofur derivates in serum and endometrial tissue after intramuscular administration. Specif...
Plasma disposition and fecal elimination of doramectin after oral or intramuscular administration in horses.
Veterinary parasitology    February 4, 2010   Volume 170, Issue 1-2 112-119 doi: 10.1016/j.vetpar.2010.01.038
Pérez R, Godoy C, Palma C, Muñoz L, Arboix M, Alvinerie M.A study was done to compare plasma disposition kinetics and the fecal elimination profile of doramectin (DRM) after oral or intramuscular (IM) administration in horses. Ten clinically healthy horses, 328-502 kg body weight (bw), were assigned to 2 experimental groups of 5 horses each. Group 1 was treated with an oral dose of 0.2 mg DRM/kg bw, while Group 2 was treated with 0.2 mg DRM/kg bw by IM route. Blood and fecal samples were collected at different times between 0.5h and 60 days post-treatment. After plasma and fecal drug extraction and derivatization, samples were analysed by high perfor...
Plasma concentrations, behavioural and physiological effects following intravenous and intramuscular detomidine in horses.
Equine veterinary journal    January 26, 2010   Volume 41, Issue 8 772-777 doi: 10.2746/042516409x421624
Mama KR, Grimsrud K, Snell T, Stanley S.Detomidine hydrochloride is used to provide sedation, muscle relaxation and analgesia in horses, but a lack of information pertaining to plasma concentration has limited the ability to correlate drug concentration with effect. Objective: To build on previous information and assess detomidine for i.v. and i.m. use in horses by simultaneously assessing plasma drug concentrations, physiological parameters and behavioural characteristics. Objective: Systemic effects would be seen following i.m. and i.v. detomidine administration and these effects would be positively correlated with plasma drug con...
Treatment of septicaemia and severe bacterial infections in foals with a new cefquinome formulation: a field study.
DTW. Deutsche tierarztliche Wochenschrift    October 10, 2009   Volume 116, Issue 9 316-320 
Rohdich N, Zschiesche E, Heckeroth A, Wilhelm C, Leendertse I, Thomas E.A multicentre field study was conducted in accordance with VICH Guideline on Good Clinical Practice (VICH 2000) to confirm the efficacy and safety of a new formulation of cefquinome for the treatment of naturally occurring severe bacterial infections and septicaemia in foals. Thirty-nine foals suffering from severe bacterial infections (such as pneumonia, gastro-enteritis, arthritis, omphalitis, or wound infections) or acute septicaemia were treated twice daily with the test product (1 mg cefquinome/kg body weight) intravenously for three days and then intramuscularly for three to 11 days. Inv...
Changes in intramuscular amino acid levels in submaximally exercised horses – a pilot study.
Journal of animal physiology and animal nutrition    August 3, 2009   Volume 94, Issue 4 455-464 doi: 10.1111/j.1439-0396.2009.00929.x
van den Hoven R, Bauer A, Hackl S, Zickl M, Spona J, Zentek J.The time-dependent changes in intramuscular amino acid (AA) levels caused by exercise and by feeding a protein/AA supplement were analysed in nine horses. Horses were submitted to a total of four standardized exercise tests (SETs). Amino acid concentrations were determined prior to, immediately after, 4 and 18 h after exercise. The experiment was subdivided into two consecutive periods of 3 weeks. In each period two SETs were performed. In the second period, horses were given a protein/AA supplement within 1 h after exercise. Significant changes in mean plasma AA levels similar to previous stu...
Pharmacokinetics of detomidine and its metabolites following intravenous and intramuscular administration in horses.
Equine veterinary journal    July 1, 2009   Volume 41, Issue 4 361-365 doi: 10.2746/042516409x370900
Grimsrud KN, Mama KR, Thomasy SM, Stanley SD.Detomidine is commonly used i.v. for sedation and analgesia in horses, but the pharmacokinetics and metabolism of this drug have not been well described. Objective: To describe the pharmacokinetics of detomidine and its metabolites, 3-hydroxy-detomidine (OH-detomidine) and detomidine 3-carboxylic acid (COOH-detomidine), after i.v. and i.m. administration of a single dose to horses. Methods: Eight horses were used in a balanced crossover design study. In Phase 1, 4 horses received a single dose of i.v. detomidine, administered 30 microg/kg bwt and 4 a single dose i.m. 30 microg/kg bwt. In Phase...
Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres.
Biomaterials    June 12, 2009   Volume 30, Issue 28 5161-5169 doi: 10.1016/j.biomaterials.2009.05.045
Florindo HF, Pandit S, Gonçalves LM, Videira M, Alpar O, Almeida AJ.Strangles is an infectious disease caused by Streptococcus equi subspecies equi that affects the upper respiratory tract of the Equidae. The control of this disease seems to be dependent on its earlier detection and prevention, but prolonged animal protection without development of strong and severe side effects has not yet been achieved. Convalescent horses exhibit a protective immune response, mainly against SeM (58 kDa), an antiphagocytic and opsonogenic S. equi M-like protein, known as the major protective antigen against strangles. Purified recombinant SeM and S. equi protein extract-entr...
Effective oxytocin treatment on placental expulsion after foaling in heavy draft mares.
The Journal of veterinary medical science    April 7, 2009   Volume 71, Issue 3 293-297 doi: 10.1292/jvms.71.293
Ishii M, Kobayashi S, Acosta TJ, Miki W, Matsui M, Yamanoi T, Miyake Y, Miyamoto A.The aim of this study was to establish the effectiveness of administration of oxytocin (OT) on placental expulsion after foaling. Four foaling mares with the placentas retained for up 1 hr after foaling received OT (50 IU) administration at 1 hr intervals before expulsion of the placenta. The changes in the plasma concentrations of OT and the PGF2alpha metabolite (PGFM) were investigated, and the influence of OT administration was considered. The results were as follows. The placenta was expelled after one to three OT administrations in all four mares that received OT. In two mares, which expe...
Pharmacokinetics of butorphanol in horses after intramuscular injection.
Journal of veterinary pharmacology and therapeutics    January 24, 2009   Volume 32, Issue 1 62-65 doi: 10.1111/j.1365-2885.2008.01004.x
Sellon DC, Papich MG, Palmer L, Remund B.A two-way cross-over study of the pharmacokinetics of butorphanol after intravenous and intramuscular administration at 0.08 mg/kg in six adult horses was performed. Heparinized venous blood samples were obtained prior to drug administration and at 10, 20, 30, 45, 60, 120, 180, 240, and 360 min after IV injection. Samples were obtained at the same time points and at 6 h and 12 h after IM injection. Physical examination parameters were recorded at each time point. Plasma butorphanol concentrations were determined by high performance liquid chromatography. No significant differences in any physi...
Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration.
Journal of veterinary pharmacology and therapeutics    November 13, 2008   Volume 31, Issue 5 399-405 doi: 10.1111/j.1365-2885.2008.00983.x
Goudah A, Abo El-Sooud K, Shim JH, Shin HC, Abd El-Aty AM.The target of the present study was to investigate the plasma disposition kinetics of levofloxacin in stallions (n = 6) following a single intravenous (i.v.) bolus or intramuscular (i.m.) injection at a dose rate of 4 mg/kg bwt, using a two-phase crossover design with 15 days as an interval period. Plasma samples were collected at appropriate times during a 48-h administration interval, and were analyzed using a microbiological assay method. The plasma levofloxacin disposition was best fitted to a two-compartment open model after i.v. dosing. The half-lives of distribution and elimination were...
Pharmacokinetics of butorphanol and evaluation of physiologic and behavioral effects after intravenous and intramuscular administration to neonatal foals.
Journal of veterinary internal medicine    October 3, 2008   Volume 22, Issue 6 1417-1426 doi: 10.1111/j.1939-1676.2008.0200.x
Arguedas MG, Hines MT, Papich MG, Farnsworth KD, Sellon DC.Despite frequent clinical use, information about the pharmacokinetics (PK), clinical effects, and safety of butorphanol in foals is not available. Objective: The purpose of this study was to determine the PK of butorphanol in neonatal foals after IV and IM administration; to determine whether administration of butorphanol results in physiologic or behavioral changes in neonatal foals; and to describe adverse effects associated with its use in neonatal foals. Methods: Six healthy mixed breed pony foals between 3 and 12 days of age were used. Methods: In a 3-way crossover design, foals received ...
Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses.
Journal of veterinary pharmacology and therapeutics    July 22, 2008   Volume 31, Issue 4 321-327 doi: 10.1111/j.1365-2885.2008.00970.x
Zozaya DH, Gutiérrez OL, Ocampo CL, Sumano LH.Pharmacokinetic parameters of fosfomycin were determined in horses after the administration of disodium fosfomycin at 10 mg/kg and 20 mg/kg intravenously (IV), intramuscularly (IM) and subcutaneously (SC) each. Serum concentration at time zero (C(S0)) was 112.21 +/- 1.27 microg/mL and 201.43 +/- 1.56 microg/mL for each dose level. Bioavailability after the SC administration was 84 and 86% for the 10 mg/kg and the 20 mg/kg dose respectively. Considering the documented minimum inhibitory concentration (MIC(90)) range of sensitive bacteria to fosfomycin, the maximum serum concentration (Cmax) obt...
Intake and excretion of disodium monomethylarsonate in horses: a speciation study.
Analytical and bioanalytical chemistry    March 9, 2008   Volume 390, Issue 8 2107-2113 doi: 10.1007/s00216-008-1976-1
Assis RA, Kuchler IL, Miekeley N, Tozzi MB.Capillary electrophoresis coupled to inductively coupled plasma mass spectrometry was used in a speciation study on disodium monomethylarsonate (DS-MMA(V)) and its metabolites in horses, to which the drug was administered by intramuscular injection on five consecutive days at a single arsenic dosage of 270 mg day(-1). Samples of urine, whole blood, plasma, and mane hair were analyzed before, during, and after drug administration. The data show that blood clearing and urinary excretion of MMA is a fast process following first-order kinetics with biological half-lives of about 38 h and 44 h for ...
Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
Journal of veterinary pharmacology and therapeutics    January 8, 2008   Volume 31, Issue 1 60-65 doi: 10.1111/j.1365-2885.2007.00929.x
Shilo Y, Britzi M, Eytan B, Lifschitz T, Soback S, Steinman A.Tramadol is a centrally acting analgesic drug that has been used clinically for the last two decades to treat moderate to moderately severe pain in humans. The present study investigated tramadol administration in horses by intravenous, intramuscular, oral as immediate-release and oral as sustained-release dosage-form routes. Seven horses were used in a four-way crossover study design in which racemic tramadol was administered at 2 mg/kg by each route of administration. Altogether, 23 blood samples were collected between 0 and 2880 min. The concentration of tramadol and its M1 metabolite were ...
Effect of repeated administration of oxytocin during diestrus on duration of function of corpora lutea in mares.
Journal of the American Veterinary Medical Association    December 18, 2007   Volume 231, Issue 12 1864-1867 doi: 10.2460/javma.231.12.1864
Vanderwall DK, Rasmussen DM, Woods GL.To determine whether IM administration of exogenous oxytocin twice daily on days 7 to 14 after ovulation blocks luteolysis and causes prolonged function of corpora lutea (CL) in mares. Methods: Prospective study. Methods: 12 mares. Methods: Beginning on the day of ovulation (day 0), jugular blood samples were collected every other day until day 40 for determination of progesterone concentration. On day 7, mares (n = 6/group) were treated with saline (0.9% NaCl) solution (control group) or oxytocin. Beginning on day 7, control mares received 3 mL of sterile saline solution every 12 hours, IM, a...
Effects of intramuscular administration of acepromazine on palmar digital blood flow, palmar digital arterial pressure, transverse facial arterial pressure, and packed cell volume in clinically healthy, conscious horses.
Veterinary surgery : VS    December 11, 2007   Volume 36, Issue 8 717-723 doi: 10.1111/j.1532-950X.2007.00325.x
Leise BS, Fugler LA, Stokes AM, Eades SC, Moore RM.To determine the magnitude and duration of effects of acepromazine administered intramuscularly (IM) on digital and systemic hemodynamic variables in clinically healthy horses. Methods: Experimental study. Methods: Healthy adult horses (n=12). Methods- An ultrasonic Doppler flow probe was surgically implanted around the medial palmar digital artery before the study. Catheters were inserted in the transverse facial artery, lateral palmar digital artery, and jugular vein. A treatment group (n=6) was administered 0.04 mg/kg body weight of acepromazine IM; control horses (n=6) were administered an...